Top Story

Pivotal Crohn's study data reveals remission rates

Phase 3 data presented at Digestive Disease Week® 2016

Read more

First ever summit of its kind...

Read more

The Scottish Medicines Consortium (SMC) has accepted AbbVie’s Humira® (adalimumab),...

Read more

NHS England is to recommission the Community Pharmacy Seasonal Influenza Vaccination programme in...

Read more

  An antiseptic chlorhexidine gel, which prevents umbilical cord infections in newborn infants...

Read more

Phase 3 trial results for Takeda’s oral proteasome inhibitor ixazomib demonstrate improved sur...

Read more

Community pharmacies could close to save £170m....

Read more

Cost-cutting programme will reduce variation in drug doses...

Read more

Bladder cancer therapy also being evaluated in Phase III study...

Read more

Internis' buffered alendronate is taken as an effervescent tablet...

Read more

The company joins with MedImmune to present data on oncology pipeline....

Read more